Class / Patent application number | Description | Number of patent applications / Date published |
424605000 | Phosphorus acid | 53 |
20080248128 | Method for treating fruit or vegetables with phosphorous ions and corresponding compositions - The present application relates to a combination for treating fruit or vegetables comprising phosphorous acid (PA) and eugenol. | 10-09-2008 |
20080311221 | LEWIS ACID AND OIL-SOLUBLE HYBRID PESTICIDE CONCENTRATE THAT SPONTANEOUSLY FORMS A WATER-BASED MICROEMULSION - A chemically and physically stable, transparent, hybrid pesticide concentrate is provided for preparation of a water-based microemulsion formulation. The pesticides preferably comprise an oil-soluble pesticide component, and a pesticide component having a Lewis acid pesticide portion and a pesticide complex portion. An inactive biphasic coupling agent for the pesticide ingredients includes a solvent capable of solvating the oil-soluble pesticide component, and two organic cosolvents capable of solvating the Lewis acid pesticide portion and the pesticide complex portion pesticide ingredients, respectively. A selected emulsifier is incorporated in the concentrate. A sufficient quantity of a complexing agent is provided to maintain the electrical potential of the final concentrate at a value of about −150 mV to about +150 mV. The inactive coupling agent and the complexing agent are sufficient relative to the quantity of the active pesticide ingredients to cause the concentrate to spontaneously form a microemulsion made up of particles that are less than 1μ when the concentrate is diluted with water. | 12-18-2008 |
20090074878 | Non-Toxic Water Soluble Inorganice Antimicrobal Polymer and Related Methods - The present invention provides a non-toxic water soluble, inorganic anti-microbial polymer for inactivating microorganisms. The polymer is obtained by forming an aqueous solution comprising alkali metal cations, phosphate anions, carbonate anions, and hydrogen ions. The polymer has antimicrobial activity while in suspension and forms a hard, contiguous, encapsulating antimicrobial transparent film when dry. The film physically disrupts encapsulated microorganisms as it is formed and once formed does not support surface microbial growth. | 03-19-2009 |
20090092681 | ARTIFICIAL CEREBROSPINAL FLUID - The present invention provides an artificial cerebrospinal fluid containing 120 to 160 mEq/L of sodium ion, 1 to 6 mEq/L of potassium ion, 75 to 155 mEq/L of chloride ion, and 5 to 45 mEq/L of bicarbonate ion, and provides an artificial cerebrospinal fluid further containing at least one component selected from the group consisting of 10 g/L or less of a reducing sugar, 5 mmol/L or less of phosphoric acid, 5 mEq/L or less of calcium ion, and 5 mEq/L or less of magnesium ion. The artificial cerebrospinal fluid of the present invention can prevent or reduce the incidence of cerebral edema and can further suppress brain cell disorders when used as an irrigation fluid or perfusion fluid in the field of neurosurgery, such as intracranial surgery, or when used as a replenishing fluid for lost cerebrospinal fluid. | 04-09-2009 |
20090092682 | FUNGICIDAL COMPOSITION FOR THROUGH PERIDERM BARK APPLICATION TO WOODY PLANTS - A fungicidal composition for topical application to woody plant periderm, the composition comprising (a) a systemic fungicide, (b) an organosiloxane surfactant, and (c) water. | 04-09-2009 |
20090098215 | DIALYSIS SOLUTIONS CONTAINING PYROPHOSPHATES - Dialysis solutions comprising pyrophosphates and methods of making and using the dialysis solutions are provided. In an embodiment, the present disclosure provides a dialysis solution comprising a stable and therapeutically effective amount of pyrophosphate. The dialysis solution can be sterilized, for example, using a technique such as autoclave, steam, high pressure, ultra-violet, filtration or combination thereof. The dialysis solution can be in the form of a concentrate. | 04-16-2009 |
20090104281 | Compositions Having a High Antiviral and Antibacterial Efficacy - A method of providing a rapid, broad spectrum bacterial control, and a rapid persistent antiviral control on a surface, and particularly a mammalian skin surface, is disclosed. In the method, a compound or composition capable of lowering skin pH to less than about 4 is applied to the skin, and preferably is allowed to remain on the skin. | 04-23-2009 |
20090117200 | Fungicide Composition Comprising a Phosphorous Acid Derivative, a Mandelamide Type Compound and a Further Fungicide Compound - The invention relates to active compound combinations, in particular within a fungicide composition, which comprise a phosphorous acid derivative (phosphonate or phosphite derivative), a compound of the mandelamide type like mandipropamid and a further fungicide compound. Such combinations are very highly suitable for controlling phytopathogenic fungi. | 05-07-2009 |
20090117201 | Multi-purpose acid compositions - The invention relates to solutions containing acidic compositions that have a pH of less than 1, are non-caustic to human tissue and are safe for human ingestion. These compositions may be used as the sole or major component of solutions such as cleansers, pharmaceuticals, food preservatives and disinfectants. The acidic compositions may be used in medical, industrial, military and household applications. The invention also relates methods of administering and using the acidic compositions of the invention. | 05-07-2009 |
20090123561 | Fungicide mixtures based on 1-methyl-pyrazol-4-ylcarboxanilides - Fungicidal mixtures, comprising as active components
| 05-14-2009 |
20090258086 | BIOFILM EXTRACELLULAR POLYSACCHARIDE SOLVATING SYSTEM - The invention provides a solvating system for the removal of biofilms which solvates the extracellular polysaccharide matrix holding it to a surface. The aqueous solvating system comprises water, a metal ion sequestering agent, and a solvating agent for an extracellular polysaccharide matrix, which is gentle enough to be used directly on human tissues, but which may also be used on hard or soft non-tissue surfaces to breakdown, and/or remove biofilms. | 10-15-2009 |
20100143491 | Organic Peracid Polymer Composition and Process for Producing the Same - It is intended to provide an organic peracid polymer composition which is stable, odorless and has sufficient water solubility and is suitably used as a bactericide, a bleaching agent and a cleaning agent. By mixing and dissolving an organic acid polymer, hydrogen peroxide and an inorganic acid and maintaining the mixture for a period ranging from 1 hour to 1 month at a temperature ranging from 10 to 80° C., the organic peracid polymer-containing composition containing an organic peracid polymer (2 to 50% by weight) and, in some cases, the hydrogen peroxide (2 to 50% by weight) and the inorganic acid (0.1 to 10% by weight) is obtained. | 06-10-2010 |
20100143492 | COAGULATION AND FIBRINOLYTIC CASCADES MODULATOR - A thromboplastin reagent comprises (i) TF, (ii) a phospholipid, and (iii) a polyP TFPI blocker. | 06-10-2010 |
20100151042 | Materials and Methods for Treating Influenza Infections - The subject invention provides materials and methods for treating various health conditions, including the prevention and/or treatment of an influenza viral infection. In a preferred embodiment, a cysteamine compound and viral therapeutic are concurrently administered to a subject to treat an influenza virus infection. More preferably, a cysteamine compound is concurrently administered with a viral therapeutic to a subject to treat influenza A, influenza B, influenza C virus infections, including avian influenza virus subtypes (such as H5N1 avian influenza virus). | 06-17-2010 |
20100173010 | Polymetaphosphate based formulations for therapy of microcrystalline arthropathies - Soluble pharmaceutical composition for the treatment of articular pathologies comprising an effective amount of a least one linear or cyclic polymetaphosphate or a soluble and pharmaceutically acceptable salt thereof, and appropriate diluents. | 07-08-2010 |
20100233287 | PREVENTING OR TREATING AGENT FOR GLAUCOMA - A preventing or treating agent for glaucoma is provided. This drug has a strong action of reducing intraocular pressure such that the intraocular pressure can be reduced even from the normal intraocular pressure. More specifically, a prophylactic or therapeutic agent for glaucoma, a preventing or treating agent for ocular hypertension, and eye drops containing (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl homopiperazine or its salt and phosphoric acid or its salt are provided. | 09-16-2010 |
20100255117 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - The instant invention provides methods and compositions for the treatment of cancer. | 10-07-2010 |
20100260863 | Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same - This invention relates to a composition for the topical or internal treatment of animal tissues to buffer and normalize the pH of the cellular environment while also effecting specific cellular membrane ion channels as a method to affect inflammation, proteases, reactive oxygen species and free radicals. | 10-14-2010 |
20100278934 | METHODS AND COMPOSITIONS FOR CONSERVING AND/OR PREPARING AN ORGAN OR TISSUE FOR TRANSPLANT - A method of conserving and/or preparing an organ or tissue for transplant for a subject, includes administering to a subject, organ or tissue in need of such treatment an effective amount of a composition including a polypeptide agent including thymosin beta 4 (TB4), an isoform, analogue or derivative of TB4 having biological activity of TB4, an N-terminal variant of TB4 having biological activity of TB4, a C-terminal variant of TB4 having biological activity of TB4, LKKTET or a conservative variant thereof, LKKTNT or a conservative variant thereof, KLKKTET or a conservative variant thereof, LKKTETQ or a conservative variant thereof, TB4 sulfoxide, TB4ala, TB9, TB10, TB11, TB12, TB13, TB14, TB15, gelsolin, vitamin D binding protein (DBP), profilin, cofilin, adsevertin, propomyosin, fincilin, depactin, Dnasel, vilin, fragmin, severin, capping protein, ?-actinin or acumentin, or a stimulating agent that stimulates production of a polypeptide agent as described above, or a conservative variant thereof, in the organ or tissue. | 11-04-2010 |
20100291230 | Novel Pesticide Compositions - Novel pesticide compositions and formulations, containing a phosphorous-containing compound and a nitrogen-releasing compound, are disclosed. These novel compositions exhibit a synergistic pesticidal activity and are particularly useful in treating pests such as nematodes (including root-not nematodes), fungi and bacteria. Methods utilizing these compositions for controlling pests, articles-of-manufacture containing same and processes of preparing same are further disclosed. | 11-18-2010 |
20100291231 | Compositions as Wound Sealant - The present invention relates to compositions which, in sprayable or form, are suitable as wound sealants for woody plants. The invention also relates to a method of protecting woody plants from infection with phytopathogenic fungi, in particular ESCA infection, using such wound sealants. | 11-18-2010 |
20100291232 | FUNGICIDAL COMPOSITION COMPRISING A PYRIDYLETHYLBENZAMIDE DERIVATIVE AND A COMPOUND CAPABLE OF INHIBITING THE TRANSPORT OF ELECTRONS OF THE RESPIRATORY CHAIN IN PHYTOPATHOGENIC FUNGAL ORGANISMS - A composition comprising at least a pyridylethylbenzamide derivative of general formula (I) (a) and a compound capable of inhibiting the transport of electrons of the respiratory chain in phytopathogenic fungal organisms (b) in an (a)/(b) weight ratio of from 0.01 to 20. A composition further comprising an additional fungicidal compound. A method for preventively or curatively combating the phytopathogenic fungi of crops by using this composition. | 11-18-2010 |
20100297257 | ANTICOAGULANT ANTAGONIST AND HEMOPHILLIA PROCOAGULANT - A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient. | 11-25-2010 |
20110008461 | INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE - A PEPCK inhibitor can include identifying a molecule that has a size capable of fitting into and interacting with the PEPCK binding site and at least one of the following: (a) a first terminal substituent having co-planar atoms acting as metal ligands to the active site metal ion PEPCK; (b) at least one of an atom or substituent at positions 2 or 3 from the first terminal substituent includes a neutral carbon center or include an oxygen, sulfur, selenium, or other atom with similar physiochemical properties; (c) at least one of an atom or substituent at positions 2 or 3 from the first terminal substituent is devoid of an electropositive atom or substituents; or (d) a second terminal substituent opposite of the first terminal substituent, said second terminal substituent having an atom that is a hydrogen boding acceptor and/or is negatively charged. | 01-13-2011 |
20110076339 | Colon Cleansing Method and Kit - A method of colon cleansing that provides superior cleansing. In an embodiment, superior cleansing of the right colon is provided. In an embodiment, a stimulant laxative is consumed at least two days prior to the day for which maximum cleansing is desired, and an osmotic purgative is consumed one day prior to the day for which maximum cleansing is desired. A regimen that administered PICO-SALAX® plus BISACODYL™ was superior in cleansing the right colon compared to PICO-SALAX® alone, and when compared to Oral Sodium Phosphate. Patient tolerability and safety were excellent. | 03-31-2011 |
20110159107 | Pesticidal Mixtures Comprising Isoxazoline Compounds II - The present invention relates to pesticidal mixtures comprising as active components
| 06-30-2011 |
20110262555 | METHODS AND COMPOSITIONS FOR REDUCING OR PREVENTING VASCULAR CALCIFICATION DURING PERITONEAL DIALYSIS THERAPY - Methods and compositions for reducing, preventing or reducing the progression of calcification in peritoneal dialysis patients are provided. In an embodiment, the present disclosure provides a method comprising administering to a patient during peritoneal dialysis therapy a dialysis solution comprising a therapeutically effective amount of pyrophosphate ranging between about 30 μM and about 400 μM. Formulations of dialysis solutions according to the dose ranges claimed in the present disclosure allow therapeutic amounts of pyrophosphate to be delivered to peritoneal dialysis patients. | 10-27-2011 |
20110287108 | PESTICIDE COMPOSITION COMPRISING A TETRAZOLYLOXIME DERIVATIVE AND A FUNGICIDE OR AN INSECTICIDE ACTIVE SUBSTANCE - The present invention relates to a pesticide composition intended for protecting plants, crops or seeds against fungal diseases or insect damages, and the corresponding methods of protection by application of the said composition. More precisely, the subject of the present invention is a pesticide composition based on a tetrazolyloxime derivative and a fungicide or an insecticide active substance or compound. | 11-24-2011 |
20120070510 | WOUND AND MUCOUS MEMBRANE DISINFECTANT - Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilisers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids. | 03-22-2012 |
20120121723 | Antimicrobial Compositions - An antimicrobial composition, including a synergistic combination of three or more agents as an active ingredient. Each of the three or more potentiating agents can be selected from the following types of compounds: sequestering agents, carbohydrates and carbohydrate derivatives, terpenes/terpenoids, amines and amine derivatives, plant-derived oils, sulfonates, phenols, fatty acids, dibenzofuran derivatives, organo isothiocyanates, quaternary ammonium compounds, peroxides and peroxide donors, and macrolide polyenes. At least two of the three or more potentiating agents are not of the same type of compound. The antimicrobial composition can have strong antimicrobial efficacy in control of microorganisms having resistance to currently used antimicrobials. | 05-17-2012 |
20120171299 | Crystallization of Poly Ammonium Phosphate in Particular Organic Material and Uses Thereof - An organic particular material and a method for producing the material is disclosed, as well as multiple uses of the material produced by the same method for use as soil improver, combating the Iberia snail, fire resisting absorption of flammable liquids as well as fire extinguisher. | 07-05-2012 |
20120282345 | PESTICIDE COMPOSITION COMPRISING PROPAMOCARB-HYDROCHLORIDE AND AN INSECTICIDE ACTIVE SUBSTANCE - The present invention relates to a pesticide composition intended for protecting plants, crops or seeds against phyto-pathogenic fungi or damaging insects, and the corresponding methods of treatment using the said composition. More precisely, the subject of the present invention is a pesticide composition based on propamocarb-HCl, an insecticide active substance and optionally a further fungicide active substance. | 11-08-2012 |
20130034614 | METHOD OF TREATING CITRUS PLANTS TO REDUCE BACTERIAL INFECTIONS - A method of treating a citrus plant is provided to reduce the incidence of one or more insect-vectored bacterial infections such as citrus greening. The method comprises the step of applying a treatment composition one or more times to the plant, wherein the treatment composition comprises an effective amount of aluminum tris(O-ethyl phosphonate). | 02-07-2013 |
20130236561 | COSMETIC FORMULATION WITH A DRY SKIN FEEL - The instant invention relates to cosmetic compositions with improved dry skin feel characteristics. In particular, the present invention relates to cosmetic formulations comprising certain amidoamines used in combination with fatty acids and selected further acids. | 09-12-2013 |
20130236562 | NOVEL METHOD FOR THE PRE- OR POST-HARVEST TREATMENT OF PLANT PRODUCTS, USING PHOSPHONIC ACID AND AN ESSENTIAL OIL - The invention relates to the pre- or post harvest fungicidal and/or bactericidal treatment of plant products, using at least phosphonic acid that is at least partially salified and eugenol or clove oil, at ambient temperature, as well as to the compositions suitable for said method. | 09-12-2013 |
20140120178 | Multi-Component Encapsulated Reactive Formulations - The present invention provides a multi-component encapsulated reactive formulation comprising a mixture of two or more dry powder components, where each dry powder component is formed from a phase inversion process involving vigorous mixing. The dry powder is stabilized by hydrophobic colloidal particles, which assist in generating stable “dry water” microdroplets. One dry powder component comprises hydrophobic colloidal particles encapsulating microdroplets comprising an aqueous solution of one reactant, and the at least one other dry powder component comprises hydrophobic colloidal particles encapsulating microdroplets comprising an aqueous solution of another reactant. When the encapsulated formulation is agitated such that the encapsulates are broken, the encapsulates rupture and the two aqueous solutions undergo a reaction upon contact. | 05-01-2014 |
20140127318 | BACTERIAL AND FUNGICIDAL COMPOSITION FOR PLANTS AND CROPS - Compositions comprising an effective amount of (1) hydrogen peroxide, an organic peroxide or a combination thereof; and (2) phosphorous acid, mono- and/or di-salts of phosphorous acid or a combination thereof are effective in preventing or controlling diseases in plants caused by pathogens. The disclosed compositions can be used by contacting a plant with an effective amount of such compositions. | 05-08-2014 |
20140170236 | USE OF PHOSPHORIC ACID - This disclosure relates to the use of phosphoric acid. In particular, this disclosure relates to the use of phosphoric acid for treating cardiovascular disorders such as atherosclerosis. This disclosure further relates to compositions, kits, methods, and the like. | 06-19-2014 |
20140170237 | ANTIMICROBIAL COMPOSITIONS CONTAINING MIXTURES OF FATTY AND HYDROXYL CARBOXYLIC ACIDS - The application is directed to cold temperature stable micro emulsion concentrate compositions comprising from about 5 to about 15% by weight of an alkyl fatty acids mixture, wherein the fatty acids mixture consists of C8 fatty acids and/or C9 fatty acids, C10 fatty acids and/or C12 fatty acids; from about 20 to 60% by weight (+)-lactic acid and/or from about 0 to about 40% by weight phosphoric acid; and from about 20 to about 40% by weight C8 to C16 mono- and/or di-alkyldiphenyloxide disulfonate (ADPODS) surfactants. The application is also directed to ready to use products comprising from about 0.02 to 0.2% by weight C9 fatty acids or C9-C10-C12 fatty acids, 0.5 to 2% by weight L(+)-lactic acid, and from about 0.5 to about 4% by weight of C8 to C16 mono- and/or di-alkyldiphenyloxide disulfonate (ADPODS) or fatty alcohol ethoxylate surfactants. | 06-19-2014 |
20140186462 | Anticoagulant Antagonist and Hemophilia Procoagulant - A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient. | 07-03-2014 |
20140242188 | Antimicrobial Compositions and Methods Employing Same - An aqueous composition with a higher-than-neutral pH includes a significant amount of one or more surfactants and large amounts of osmotically active solutes. This composition, as well as an acidic counterpart and solid materials, can be used in a variety of applications such as wound care, oral care, medical equipment reprocessing, healthcare acquired infection and implant treatment. | 08-28-2014 |
20140271915 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE - Use of a derivative containing C—O—P bonds in a controlled release form to treat patients with kidney failure. Moreover, it comprises the use of said derivatives together with other active substances, which particularly may be selected from a list comprising a calcimirnetic, vitamin, phosphate binder, thiosulfate, bisphosphonate, pyrophosphate, citrate, diuretic, antihypertensive and anticholesteraemic agent. | 09-18-2014 |
20140302166 | COMPOSITION OF DIALYSIS LIQUID COMPRISING CRYSTALLISATION INHIBITOR SUBSTANCES - This invention relates to a composition that comprises inositol phosphates and/or bisphosphonates, and to the use thereof to prevent the loss of substances of biological interest in the body of patients subjected to dialysis and to maintain sufficient physiological levels of said substances to regulate physiological and/or pathological processes, these substances being inhibitors of pathological crystallisation. | 10-09-2014 |
20140302167 | SHIPS' BALLAST WATER TREATMENT AGENT AND TREATMENT METHOD OF SHIPS' BALLAST WATER USING THE SAME - A ships' ballast water treatment agent is obtained by blending phosphate and sodium hydroxide into a hypochlorite solution and has pH of 10 to 13. A blending amount of phosphate is preferably such that a weight ratio of effective chlorine to phosphate acid (PO | 10-09-2014 |
20140322348 | COMBINATIONS OF ANTIFUNGAL COMPOUNDS AND TEA TREE OIL - There is disclosed a method for treating a plant infection caused by a fungus of the class oomycetes, comprising applying to the plant a combination of tea tree oil (TTO) and a synthetic fungicidal compound. Other embodiments are also disclosed. | 10-30-2014 |
20150017257 | Acidic Electrolyzed Water, Manufacturing Method Therefor, and Cleanser And Disinfectant Containing Acidic Electrolyzed Water - To provide acidic electrolyzed water, a method for manufacturing acidic electrolyzed water, and a cleanser and a disinfectant containing acidic electrolyzed water which has disinfecting power for a long period of time, and which reduces the burden on living tissue. The acidic electrolyzed water has an effective chlorine concentration of 15 ppm or more, osmotic pressure from 235 mOsm to 435 mOsm, and a chlorine-based electrolyte content of 0.1 mass % or less in terms of sodium chloride. | 01-15-2015 |
20150030693 | ANTI-TUMOR AQUEOUS SOLUTION, ANTI-CANCER AGENT, AND METHODS FOR PRODUCING SAID AQUEOUS SOLUTION AND SAID ANTI-CANCER AGENT - An object of the present invention is to provide an antitumor aqueous solution and an anticancer agent, both of which can kill cancer cells while having virtually no effects on normal cells, and to provide methods for producing the antitumor aqueous solution and the anticancer agent. The method of the invention for producing an antitumor aqueous solution for killing cancer cells includes an aqueous solution preparation step of preparing an aqueous solution through addition, to water, of a solute containing at least one of disodium hydrogen phosphate (Na | 01-29-2015 |
20150093450 | METHODS AND COMPOSITIONS FOR REDUCING OR PREVENTING VASCULAR CALCIFICATION DURING PERITONEAL DIALYSIS THERAPY - Methods and compositions for reducing, preventing or reducing the progression of calcification in peritoneal dialysis patients are provided. In an embodiment, the present disclosure provides a method comprising administering to a patient during peritoneal dialysis therapy a dialysis solution comprising a therapeutically effective amount of pyrophosphate ranging between about 30 μM and about 400 μM. Formulations of dialysis solutions according to the dose ranges claimed in the present disclosure allow therapeutic amounts of pyrophosphate to be delivered to peritoneal dialysis patients. | 04-02-2015 |
20150297634 | Materials and Methods for Preventing and Treating Anastomotic Leaks - Materials and methods for preventing and treating anastomotic leaks are disclosed. Data establishes that pathogenic microbes interfere with establishing epithelial cell barriers in anastomoses and, more generally, with the reconnection of any two portions of like or different tissues comprising epithelia. Suitable prophylactic and therapeutic composition comprise, e.g., a phosphorylated high molecular weight polyethylene glycol compound. | 10-22-2015 |
20150320795 | COMPOSITIONS AND METHODS COMPRISING POLYETHYLENE GLYCOL AND MAGNESIUM FOR TREATMENT OF NEURONAL INJURY - The disclosure provides compositions, methods and kits for treatment of neuronal injury. In one embodiment, the composition comprises polyethylene glycol (PEG), and magnesium in one composition. In another embodiment, the composition comprises PEG, and magnesium, where the PEG is in separate composition and the magnesium is in a separate composition. In yet another embodiment, the PEG and/or the magnesium may be administered to treat spinal cord injury. | 11-12-2015 |
20150374752 | COMPOSITION OF DIALYSIS LIQUID COMPRISING CRYSTALLISATION INHIBITOR SUBSTANCES - This invention relates to a composition that comprises inositol phosphates and/or bisphosphonates, and to the use thereof to prevent the loss of substances of biological interest in the body of patients subjected to dialysis and to maintain sufficient physiological levels of said substances to regulate physiological and/or pathological processes, these substances being inhibitors of pathological crystallisation. | 12-31-2015 |
20160066571 | DISINFECTANT COMPOSITION CONTAINING QUATERNARY AMMONIUM COMPOUNDS - Disinfectant compositions disclosed herein comprise at least one biocidal quaternary ammonium compound, hydrogen peroxide, and optionally inorganic acid and/or organic acid. Particularly, a composition comprising a biocidal quaternary ammonium chloride compound, hydrogen peroxide, and C1 to C8 carboxylic acid, mono-, di- and tricarboxylic acid enhances significantly its antimicrobial activities of either hydrogen peroxide or the quaternary ammonium chloride alone. | 03-10-2016 |
20160088846 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF - Aspects relate to an aqueous composition for use on produce. The aqueous composition includes an acid, an organic diol, and an oxidizing agent in the form of chlorine, wherein the aqueous composition has acidic pH and has antimicrobial activity. | 03-31-2016 |